RKDA · XBRL financial data

Arcadia Biosciences financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (RKDA's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue from contracts with customers	1,597	1,170*	1,255	1,306	1,537	1,216*	1,200	1,455	1,302	901*	1,100	1,443
Cost of goods and services sold	1,102	670*	820	633	1,032	827*	682	824	884	709*	700	812
Research and development	305	332*	272	10	24	13*	0	9	0	0*	—	0
Selling, general and administrative	3,443	3,423*	3,189	2,683	2,241	2,655*	1,738	2,123	1,570	1,567*	1,179	1,127
Operating income (loss)	(3,242)	(3,364)*	(3,064)	1,980	(1,760)	(2,279)*	530	(501)	(1,152)	(1,375)*	(779)	(496)
Other income (expense)	17	12*	3	150	15	(137)*	0	1,071	1,698	(461)*	(1,504)	(2,781)
Income tax expense (benefit)	0	7*	—	0	0	8*	—	—	—	year only	—	—
Net income (loss)	(2,567)	(2,853)*	(2,423)	1,061	(1,612)	(4,064)*	2,599	(4,458)	856	(1,336)*	(4,385)	(6,266)
Earnings per share, basic USD per share	(1.89)	—	(1.78)	0.78	(1.18)	(2.98)*	1.90	(3.26)	0.63	(0.97)*	(2.11)	(2.09)
Earnings per share, diluted USD per share	(1.89)	—	(1.78)	0.78	(1.18)	(2.98)*	1.90	(3.26)	0.62	(0.98)*	(2.11)	(2.09)
Weighted average shares, basic thousands of shares	1,360	1,359*	1,362	1,363	1,364	1,365*	1,366	1,367	1,367	1,372*	2,083	2,993
Weighted average shares, diluted thousands of shares	1,360	1,359*	1,362	1,363	1,364	1,365*	1,366	1,367	1,372	1,367*	2,083	2,993

Fiscal quarters (RKDA's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	10,611	6,518	3,317	5,504	3,936	4,242	3,159	1,376	1,120	259	954	4,178
Short-term investments	5,089	5,124	5,184	2,604	2,640	0	—	3,067	4,765	4,304	2,766	0
Inventory	2,657	1,958	1,831	978	835	904	1,285	1,489	1,457	1,212	840	930
Prepaid and other current assets	1,093	807	535	537	521	931	727	383	214	156	184	72
Total current assets	20,006	14,972	11,642	12,434	10,711	9,242	8,846	7,579	8,387	6,356	5,169	5,739
Property and equipment, net	468	384	328	54	55	41	28	12	10	8	0	0
Right-of-use asset	1,147	792	695	513	306	137	19	10	0	0	—	—
Total assets	23,466	19,705	16,046	17,369	15,241	13,517	12,990	7,788	8,584	6,546	5,323	5,893
Total current liabilities	3,885	3,590	2,878	2,698	2,328	2,563	2,216	1,839	2,285	2,059	1,365	1,646
Lease liability, non-current	347	155	21	11	0	0	—	—	—	—	—	—
Total liabilities	8,068	7,002	5,563	5,803	5,092	7,294	4,085	3,255	3,141	2,406	2,438	5,260
Accumulated deficit	(268,987)	(271,840)	(274,263)	(273,202)	(274,814)	(278,878)	(276,279)	(280,737)	(279,881)	(281,217)	(285,602)	(291,868)
Total stockholders' equity	15,536	12,841	10,621	11,704	10,287	6,223	—	—	—	—	—	—
Total liabilities and equity	23,466	19,705	16,046	17,369	15,241	13,517	12,990	7,788	8,584	6,546	5,323	5,893
Common shares outstanding (cover page) thousands of shares	1,110	1,363	1,363	1,363	1,365	1,367	1,367	1,367	1,373	2,057	2,057	2,409

Fiscal quarters (RKDA's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(2,567)	(2,853)*	(2,423)	1,061	(1,612)	(4,064)*	2,599	(4,458)	856	(1,336)*	(4,385)	(6,266)
Stock-based compensation	162	144*	138	102	155	117*	78	86	53	17*	15	14
Net cash from operating activities	(2,885)*	(4,145)*	(3,210)	(2,456)*	(1,752)*	(2,209)*	(1,588)	(2,033)*	(257)*	(861)*	(1,099)	(319)*
Purchases of property and equipment	0*	0*	13	3*	0*	0*	0	0*	0*	0*	—	—
Net cash from investing activities	5*	52*	4	4,643*	180*	2,515*	500	250*	0*	0*	0	0*
Net cash from financing activities	7*	0*	5	0*	4*	0*	5	0*	1*	0*	1,794	3,543*
Net change in cash	(2,873)*	(4,093)*	(3,201)	2,187*	(1,568)*	306*	(1,083)	(1,783)*	(256)*	(861)*	695	3,224*

SIC 1311 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 1311 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Arcadia Biosciences	4,178	1,443	(319)*	2.4M	13.1 quarters	Q2 FY26 10-QJun 30, 2026
New Concept Energy	304	41	(14)*	5.1M	21.7 quarters	Q2 FY26 10-QJun 30, 2026
Barnwell Industries	4,467	3,379	not reported	14.4M	—	Q3 FY26 10-QJun 30, 2026
Battalion Oil	83,097	48,129	8,778*	57.3M	—	Q2 FY26 10-QJun 30, 2026
Viking Global Technologies	394	0	(399)*	281.8M	1.0 quarters	Q2 FY26 10-QJun 30, 2026
Trio Petroleum	23,204	349	(397)*	5.3M	27.3 quarters	Q3 FY26 10-QJul 31, 2026
Mexco Energy	1,293	1,983	1,451	2.0M	—	Q1 FY27 10-QJun 30, 2026
Okmin Resources	22	0*	15*	128.5M	—	Q4 FY26 10-KJun 30, 2026
Blue Dolphin Energy	30,715	144,255	38,202*	14.9M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.